Updated

AT&T Says Data From 109 Million U.S. Customer Accounts Illegally Downloaded

Reuters | July 12, 2024

By David Shepardson WASHINGTON (Reuters) -AT&T said on Friday the company suffered a massive hacking incident as data from about 109 million customer accounts containing records of calls and texts from 2022 was illegally downloaded in April. The U.S. telecom company said the FBI is investigating and at least one person has been arrested after […]

Nvidia leads Nasdaq and S&P 500 to record highs

Reuters | July 10, 2024

By Noel Randewich and Ankika Biswas NEW YORK (Reuters) -The Nasdaq and S&P 500 hit record highs on Wednesday fueled by gains in Nvidia and other Wall Street heavyweights ahead of inflation data and quarterly earnings reports due this week. It was the fifth straight day of intraday record highs for the S&P 500 and […]

Chewy executives alarmed at ‘Roaring Kitty’ stake in pet-product retailer

Reuters | July 1, 2024

By Manas Mishra, Greg Roumeliotis and Suzanne McGee (Reuters) -Stock influencer Keith Gill, known as “Roaring Kitty,” unveiled a 6.6% stake in Chewy on Monday, a surprise move that alarmed executives at the U.S. pet products company. The Chewy stake is Gill’s first known investment beyond GameStop. A link connects these two investments: Ryan Cohen, […]

Warren Buffett donates record $5.3 billion Berkshire shares to charity

Reuters | June 28, 2024

By Jonathan Stempel (Reuters) -Warren Buffett donated another $5.3 billion of Berkshire Hathaway stock to the Bill & Melinda Gates Foundation and four family charities, his biggest annual donation since he began making them in 2006. Buffett’s donation boosted his overall giving to the charities to about $57 billion, including to the family charities in […]

Factbox-US energy sector deals accelerate in quest for reserves

Reuters | June 27, 2024

(Reuters) – The consolidation wave in the U.S. energy sector that triggered $250 billion worth of deals in 2023 has stretched into this year, as companies look for opportunities to deploy their cash hoard and boost their oil and gas reserves. The total value of deals in January and February hit the highest level since […]

General Mills sees tepid annual profit, posts Q4 sales decline as demand falters

Reuters | June 26, 2024

By Anuja Bharat Mistry (Reuters) -Cheerios cereal maker General Mills forecast annual profit below estimates on Wednesday and posted a bigger-than-expected drop in quarterly sales hurt by lower demand for its snack bars and pet food, as well as higher input costs. The company also expects annual dollar value growth in its businesses to be […]

Barclays asked by watchdog to review private equity exposure, source says

Reuters | June 14, 2024

LONDON (Reuters) – Britain’s Prudential Regulation Authority (PRA) has asked Barclays to review its exposure to leveraged finance, a source familiar with the matter said on Friday, part of an industry-wide probe into lenders’ exposure to the private equity industry. The Bank of England in April said very few banks had a clear idea of […]

Yelp Can Sue Reputation Company: Finally

Reuters | June 7, 2024

By Jonathan Stempel (Reuters) -Yelp can pursue a lawsuit accusing a reputation management company of fraudulently advertising its ability to remove “bad” reviews from the business review website. In a decision late Thursday night, U.S. District Judge William Alsup in San Francisco said Yelp can pursue trademark infringement and unfair competition claims against ReviewVio, which […]

Nvidia Overtakes Apple as No. 2 Most Valuable Company

Reuters | June 6, 2024

(This June 5 story has been corrected to show Nvidia’s market cap gain was nearly $150 billion, not $150 million, in paragraph 10) By Noel Randewich (Reuters) – Nvidia’s rallied to record highs on Wednesday, with the artificial intelligence chipmaker’s valuation breaching the $3 trillion mark and overtaking Apple to become the world’s second most […]

Merck to buy eye-focused drug developer EyeBio for as much as $3 billion

Reuters | May 29, 2024

By Christy Santhosh (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases. The drugmaker agreed to pay $1.3 billion in cash and another $1.7 billion in future milestone-based payments for EyeBio, and […]

Next Page »

Wait! Before you go...

Always be feeding your money brain. Claim one or all of the FREE offers from some of our partners below.

x